Beam Therapeutics Inc. 10-Q filing
Filed 2025-11-04 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-263542
- Form type
- 10-Q
- CIK
- 0001745999
- Primary document
- https://www.sec.gov/Archives/edgar/data/1745999/000119312525263542/beam-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Beam Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $25.6M | - | - |
| Operating Income | $-366.2M | - | - |
| Net Income | $-324.3M | - | - |
| Eps Basic | -3.32 | - | - |
| Eps Diluted | -3.32 | - | - |
| Cash And Equivalents | $268.0M | - | - |
| Total Assets | $1.3B | - | - |
| Total Liabilities | $345.1M | - | - |
| Shareholders Equity | $966.0M | - | - |
| Operating Cash Flow | $-261.8M | - | - |
| Capital Expenditures | $11.2M | - | - |